AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,914 | -42.5% | 300,000 | 0.0% | 0.08% | -20.4% |
| Q2 2023 | $3,327 | -57.7% | 300,000 | -41.4% | 0.10% | -77.9% |
| Q1 2023 | $7,859 | -29.2% | 511,962 | +2.4% | 0.47% | -24.6% |
| Q4 2022 | $11,095 | -99.7% | 500,000 | +100.0% | 0.62% | +255.7% |
| Q3 2022 | $4,083,000 | +12.4% | 250,000 | 0.0% | 0.17% | -10.3% |
| Q2 2022 | $3,633,000 | -21.3% | 250,000 | 0.0% | 0.19% | +0.5% |
| Q1 2022 | $4,618,000 | -22.3% | 250,000 | 0.0% | 0.19% | +19.9% |
| Q4 2021 | $5,943,000 | +69.3% | 250,000 | +75.4% | 0.16% | +103.8% |
| Q3 2021 | $3,510,000 | -0.3% | 142,500 | 0.0% | 0.08% | +11.3% |
| Q2 2021 | $3,521,000 | +13.3% | 142,500 | 0.0% | 0.07% | +29.1% |
| Q1 2021 | $3,108,000 | -14.5% | 142,500 | 0.0% | 0.06% | -29.5% |
| Q4 2020 | $3,637,000 | -9.3% | 142,500 | 0.0% | 0.08% | -19.6% |
| Q3 2020 | $4,011,000 | -18.9% | 142,500 | -18.6% | 0.10% | -29.7% |
| Q2 2020 | $4,946,000 | – | 175,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |